Human Genome (NASDAQ: HGSI) closed at $19.97. HGSI's Benlysta, a lupus treatment, is expected to have phase 3 data released on November 2. HGSI November option implied volatility is at 249, December is at 170, January is at 143 and April is at 112, according to Track Data, suggesting large movement.
NASDAQ 100 (NASDAQ: QQQQ) overall implied volatility at 24; 26-week average is 28.
Semiconductor Holders Trust-SMH overall volatility at 29; 26-week average is 33.

Human Genome.gif)
.gif)




